Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

STAAR Surgical Company

SR3
Current price
25.53 EUR 0 EUR (0.00%)
Last closed 26.43 EUR
ISIN US8523123052
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange Frankfurt Exchange
Capitalization 1 353 731 924 EUR
Yield for 12 month -22.92 %
1Y
3Y
5Y
10Y
15Y
SR3
21.11.2021 - 28.11.2021

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Address: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

139.41 EUR

P/E ratio

66.2927

Dividend Yield

Current Year

+305 766 134 EUR

Last Year

+269 705 618 EUR

Current Quarter

+84 015 390 EUR

Last Quarter

+93 892 580 EUR

Current Year

+239 604 608 EUR

Last Year

+211 847 949 EUR

Current Quarter

+64 950 468 EUR

Last Quarter

+74 362 961 EUR

Key Figures SR3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 33 442 050 EUR
Operating Margin TTM 6.49 %
PE Ratio 66.2927
Return On Assets TTM 3.39 %
PEG Ratio
Return On Equity TTM 5.4 %
Wall Street Target Price 139.41 EUR
Revenue TTM 344 896 032 EUR
Book Value 8.79 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.3 %
Dividend Yield
Gross Profit TTM 225 786 903 EUR
Earnings per share 0.41 EUR
Diluted Eps TTM 0.41 EUR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 101.8 %
Profit Margin 6.38 %

Dividend Analytics SR3

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SR3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SR3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 66.2927
Forward PE 238.0952
Enterprise Value Revenue 3.6988
Price Sales TTM 3.925
Enterprise Value EBITDA 40.1538
Price Book MRQ 3.5645

Financials SR3

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SR3

For 52 weeks

25.88 EUR 48.51 EUR
50 Day MA 28.89 EUR
Shares Short Prior Month
200 Day MA 34.95 EUR
Short Ratio
Shares Short
Short Percent